Navigation Links
Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March
Date:4/19/2015

New York, New York (PRWEB) April 19, 2015

New court documents issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) indicate that Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) continue to mount in the federal litigation underway in U.S. District Court, District of South Carolina. According to the April 15th filing, at least 2,185 new cases have been filed in the proceeding on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. This represents an increase of 110 filings since the Panel issued its previous report on March 16th. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

“Our Firm is representing clients in this proceeding, and our legal staff continues to receive requests for case evaluations from individuals who allegedly developed diabetes due to Lipitor. Considering that Lipitor has ranked among the best selling drugs in the world, we are not surprised by the continued growth of this litigation,*” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing numerous victims of defective medical devices and drugs including Lipitor. The Firm continues to offer free and confidential Lipitor lawsuit evaluations to individuals who developed diabetes after use of this cholesterol statin.

Lipitor Litigation
According to court documents, the Lipitor lawsuits involving the alleged development of Type 2 diabetes began to mount in U.S. courts after the U.S. Food & Drug Administration (FDA) announced in February 2012 that all statin labels would be updated to include information about their potentially harmful effects on blood glucose levels. Initially, fewer than two dozen cases were transferred to the multidistrict litigation when it was created by the JPML in February 2014.

Court records indicate that all of the cases pending in the District of South Carolina accuse Pfizer Inc. of concealing data linking Lipitor to diabetes, and of failing to warn the public and medical community about this risk in order to protect the profits it derived from sales of the drug. The lawsuits further allege the modifications made to the Lipitor label in response to the FDA’s 2012 mandate still do not adequately warn patients about its association with the disorder.

Lipitor patients who allegedly developed Type 2 diabetes due to the medication may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury related damages. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*usatoday30.usatoday.com/news/health/medical/health/medical/treatments/story/2011-12-28/Against-odds-Lipitor-became-worlds-top-seller/52250720/1, USA Today, December 28, 2011

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have ben able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.lipitorlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12664179.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Lawsuits Continue to Mount, as Bernstein Liebhard LLP Notes Filing of New Claim Alleging an Association Between Lipitor and Diabetes
2. New Lipitor Diabetes Lawsuit Alleges Statin Drug Caused Woman to Develop Type 2 Diabetes, Learns Wright & Schulte LLC
3. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Criticism of New Statin Guidelines That Could Result in Millions of New Lipitor Prescriptions
4. As Lipitor Lawsuits Mount, Bernstein Liebhard LLP Notes Publication of New Study with Possible Explanation for Link between Statins and Diabetes
5. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
6. Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial
7. Lipitor Lawsuits Continue to Be Filed in South Carolina Litigation, Bernstein Liebhard LLP Reports
8. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of Type 2 Diabetes Claims in Federal Lipitor Litigation
9. South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports
10. Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
11. Lipitor Lawsuit News: New Case Management Order Issued in Federal Lipitor Litigation, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... ... December 05, 2018 , ... Advanced Clinical, ... services, announced its new office location in Paris, France during the Partnerships in ... trial operations in Europe and additional in-country personnel. , “The new office broadens ...
(Date:12/5/2018)... ... December 05, 2018 , ... What is Rosacea: ... are poorly understood. It manifests on the face, especially the cheeks, chin, nose ... cause enormous social and psychological problems. , Although it is considered incurable, the ...
(Date:12/5/2018)... ... , ... Dr. Jessica Allen of Northern Colorado Periodontics is pleased to offer ... in the Fort Collins area. Dr. Allen joins an elite class of periodontists ... lost to gum disease. , "Gum disease is a problem that many people have, ...
(Date:12/5/2018)... ... December 05, 2018 , ... You can now experience two ... LTRMN , is a powerhouse in the cannabis industry with several brands including ... is an industry leading, award winning , botanical terpene company that focuses ...
(Date:12/5/2018)... ... December 05, 2018 , ... To change the world, we ... at the DoubleTree Hilton Hotel in Newark, California. Led by world-renowned nursing theorist ... Watson Caring Science Institute, participants and esteemed guests discussed the impact of caring ...
Breaking Medicine News(10 mins):
(Date:12/6/2018)... (PRWEB) , ... December 06, 2018 , ... It’s easy to get sick during cold ... follows. According to the CDC, someone with the flu can spread it to others up ... made when people with the flu cough, sneeze or talk. While most people recover from ...
(Date:12/5/2018)... ... , ... Trivellini Tech announces the latest version of Trivellini system ... as Mamba Nano, Trivellini Long Hair introduces the ability to harvest long hair grafts ... the same capabilities as the last generation but it can also be programmed to ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... Waters , **An FDAnews Webinar**, Tuesday, Dec. 18, 2018, 1:30 p.m. - ... more vulnerable they become. , Cybersecurity is becoming an everyday risk. , ...
Breaking Medicine Technology: